-
1
-
-
77953696525
-
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
-
SMOLEN JS, LANDEWE R, BREEDVELD FC et al.: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69:964-75.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 964-975
-
-
Smolen, J.S.1
Landewe, R.2
Breedveld, F.C.3
-
2
-
-
77954984854
-
Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: A meta-analysis of clinical and radiographic remission
-
KURIYA B, ARKEMA EV, BYKERK VP, KEYSTONE EC: Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission. Ann Rheum Dis 2010;69:1298-304.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 1298-1304
-
-
Kuriya, B.1
Arkema, E.V.2
Bykerk, V.P.3
Keystone, E.C.4
-
4
-
-
1242342194
-
Long-term treatment of rheumatoid arthritis with tumour necrosis factor alpha blockade: Outcome of ceasing and restarting biologicals
-
BUCH MH, MARZO-ORTEGA H, BINGHAM SJ, EMERY P: Long-term treatment of rheumatoid arthritis with tumour necrosis factor alpha blockade: outcome of ceasing and restarting biologicals. Rheumatology (Oxford) 2004;43:243-4.
-
(2004)
Rheumatology (Oxford)
, vol.43
, pp. 243-244
-
-
Buch, M.H.1
Marzo-Ortega, H.2
Bingham, S.J.3
Emery, P.4
-
5
-
-
83255161975
-
The efficacy and safety of reinstitution of tocilizumab in patients with relapsed active rheumatoid arthritis after long-term withdrawal of tocilizumab: Retreatment of patients with rheumatoid arthritis with novel anti-IL-6 receptor antibody after a long-term interval following SAMURAI: The RONIN study
-
SAGAWA A: The efficacy and safety of reinstitution of tocilizumab in patients with relapsed active rheumatoid arthritis after long-term withdrawal of tocilizumab: retreatment of patients with rheumatoid arthritis with novel anti-IL-6 receptor antibody after a long-term interval following SAMURAI: the RONIN study. Mod Rheumatol 2011;21:352-8.
-
(2011)
Mod Rheumatol
, vol.21
, pp. 352-358
-
-
Sagawa, A.1
-
6
-
-
67649755653
-
Effect of discontinuing TNF-alpha antagonist therapy in patients with remission of rheumatoid arthritis
-
BROCQ O, MILLASSEAU E, ALBERT C et al.: Effect of discontinuing TNF-alpha antagonist therapy in patients with remission of rheumatoid arthritis. Joint Bone Spine 2009;76:350-5.
-
(2009)
Joint Bone Spine
, vol.76
, pp. 350-355
-
-
Brocq, O.1
Millasseau, E.2
Albert, C.3
-
7
-
-
19944431840
-
Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twelve-month randomized, double-blind, placebo-controlled trial
-
QUINN MA, CONAGHAN PG, O'CONNOR PJ et al.: Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:27-35.
-
(2005)
Arthritis Rheum
, vol.52
, pp. 27-35
-
-
Quinn, M.A.1
Conaghan, P.G.2
O'Connor, P.J.3
-
8
-
-
77956042108
-
Patients with RA in remission on TNF blockers: When and in whom can TNF blocker therapy be stopped?
-
SALEEM B, KEEN H, GOEB V et al.: Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped? Ann Rheum Dis 2010;69:1636-42.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 1636-1642
-
-
Saleem, B.1
Keen, H.2
Goeb, V.3
-
9
-
-
77954973766
-
Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study
-
TANAKA Y, TAKEUCHI T, MIMORI T et al.: Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study. Ann Rheum Dis 2010;69:1286-91.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 1286-1291
-
-
Tanaka, Y.1
Takeuchi, T.2
Mimori, T.3
-
10
-
-
79959795633
-
Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity scoresteered therapy: Subanalysis of the BeSt study
-
VAN DEN BROEK M, KLARENBEEK NB, DIRVEN L et al.: Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity scoresteered therapy: subanalysis of the BeSt study. Ann Rheum Dis 2011;70:1389-94.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 1389-1394
-
-
Van Den Broek, M.1
Klarenbeek, N.B.2
Dirven, L.3
-
11
-
-
34547444116
-
Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis
-
VAN DER BIJL AE, GOEKOOP-RUITERMAN YP, DE VRIES-BOUWSTRA JK et al.: Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis. Arthritis Rheum 2007;56:2129-34.
-
(2007)
Arthritis Rheum
, vol.56
, pp. 2129-2134
-
-
Van Der Bijl, A.E.1
Goekoop-Ruiterman, Y.P.2
De Vries-Bouwstra, J.K.3
-
12
-
-
84863963952
-
Withdrawal of adalimumab in early rheumatoid arthritis patients who attained stable low disease activity with adalimumab plus methotrexate: Results of a phase 4, double-blind, placebo-controlled trial
-
KAVANAUGH A, EMERY P, FLEISCHMANN R et al.: Withdrawal of adalimumab in early rheumatoid arthritis patients who attained stable low disease activity with adalimumab plus methotrexate: results of a phase 4, double-blind, placebo-controlled trial. Arthritis Rheum 2011;63:S665-S666.
-
(2011)
Arthritis Rheum
, vol.63
-
-
Kavanaugh, A.1
Emery, P.2
Fleischmann, R.3
-
13
-
-
84871407614
-
Discontinuation of adalimuman without functional and structural progress after attaining remission in patients with rheumatoid arthritis
-
TANAKA Y, HIRATA S, FUKUYO S et al.: Discontinuation of adalimuman without functional and structural progress after attaining remission in patients with rheumatoid arthritis. Arthritis Rheum 2011;63:S962.
-
(2011)
Arthritis Rheum
, vol.63
-
-
Tanaka, Y.1
Hirata, S.2
Fukuyo, S.3
-
14
-
-
84863417317
-
Efficacy of an induction therapy with adalimumab plus methotrexate versus methotrexate monotherapy in recent onset rheumatoid arthritis-an investigator initiated randomized controlled trial
-
DETER J, BASTIAN H, LISTING J et al.: Efficacy of an induction therapy with adalimumab plus methotrexate versus methotrexate monotherapy in recent onset rheumatoid arthritis-an investigator initiated randomized controlled trial. Arthritis Rheum 2011;63:S664-S665.
-
(2011)
Arthritis Rheum
, vol.63
-
-
Deter, J.1
Bastian, H.2
Listing, J.3
-
15
-
-
82955189834
-
Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: Impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study)
-
KAINE J, GLADSTEIN G, STRUSBERG I et al.: Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study). Ann Rheum Dis 2012;71:38-44.
-
(2012)
Ann Rheum Dis
, vol.71
, pp. 38-44
-
-
Kaine, J.1
Gladstein, G.2
Strusberg, I.3
-
16
-
-
33750324355
-
Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: Results from the trial of etanercept and methotrexate with radiographic and patient outcomes
-
LANDEWÉ R, VAN DER HEIJDE D, KLARESKOG L, VAN VOLLENHOVEN R, FATENEJAD S: Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes. Arthritis Rheum 2006;54:3119-25.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 3119-3125
-
-
Landewé, R.1
Van Der Heijde, D.2
Klareskog, L.3
Van Vollenhoven, R.4
Fatenejad, S.5
-
17
-
-
84867398615
-
Down-titration and discontinuation of infliximab in rheumatoid arthritis patients with stable low disease activity and stable treatment: An observational cohort study
-
Apr. 13. Epub ahead of print
-
VAN DER MAAS A, KIEVIT W, VAN DEN BEMT BJ, VAN DEN HOOGEN FH, VAN RIEL PL, DEN BROEDER AA: Down-titration and discontinuation of infliximab in rheumatoid arthritis patients with stable low disease activity and stable treatment: an observational cohort study. Ann Rheum Dis y2012 Apr. 13. [Epub ahead of print]
-
(2012)
Ann Rheum Dis
-
-
Van Der Maas, A.1
Kievit, W.2
Van Den Bemt, B.J.3
Van Den Hoogen, F.H.4
Van Riel, P.L.5
Den Broeder, A.A.6
|